Table 1.
Group A | Group B | Total | |
---|---|---|---|
Gender | |||
Male | 20 | 8 | 28 |
Female | 12 | 0 | 12 |
Age | |||
Mean ± SD (yrs) | 59.3 ± 10.1 | 67.0 ± 7.1 | 65.5 ± 9.4 |
Range (yrs) | 42-78 | 55-73 | 42-78 |
Carcinoma location | |||
Upper | 16 | 2 | 18 |
Midddle | 14 | 4 | 18 |
Lower | 2 | 2 | 4 |
p- stage | |||
T | |||
T is | 0 | 1 | 1 |
T 1a | 8 | 2 | 10 |
T 1b | 10 | 3 | 13 |
T 2 | 8 | 1 | 9 |
T 3 | 6 | 1 | 7 |
T 4a and T 4b | 0 | 0 | 0 |
N | |||
N0 | 22 | 7 | 29 |
N1a | 8 | 1 | 9 |
N1b | 2 | 0 | 2 |
N2 and N3 | 0 | 0 | 0 |
M | |||
M0 | 32 | 8 | 40 |
M1 | 0 | 0 | 0 |
H | |||
H1 | 32 | 8 | 40 |
H2 | 0 | 0 | 0 |
G | |||
Gx | 5 | 0 | 5 |
G1 | 9 | 3 | 12 |
G2 | 16 | 4 | 20 |
G3 | 2 | 1 | 3 |
G4 | 0 | 0 | 0 |
TNM-stage | |||
0 | 0 | 1 | 1 |
Ia | 7 | 3 | 10 |
Ib | 14 | 1 | 15 |
II | 10 | 3 | 13 |
IIIa | 1 | 0 | 1 |
IIIb and IV | 0 | 0 | 0 |